Madrid

• A Study of Navlimetostat (BMS986504) in Participants with Pre-treated Advanced or Metastatic Non-small Cell Lung Cancer with Homozygous MTAP … Recruiting
  2024-519814-29-00 4 2025-09-12 Advanced or Metastatic Non-small Cell Lung Cancer
• A study to evaluate the efficacy and safety of ruxolitinib cream in children (6 to <12 years old) with non-segmental vitiligo Recruiting
  2024-513171-41-00 5 2025-09-11 Vitiligo
• Study of Trastuzumab Deruxtecan with Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer … Recruiting
  2024-516982-35-00 5 2025-09-11 Ovarian Cancer
• A study of Navenibart in Participants with Hereditary Angioedema Recruiting
  2025-521660-35-00 5 2025-09-11 Hereditary Angioedema
• A study to investigate the efficacy and safety of brivekimig in adult participants with ulcerative colitis. Recruiting
  2024-515241-41-00 4 2025-09-10 Ulcerative Colitis
• A phase III placebo-controlled efficacy and safety study of mocravimod as an adjunctive and maintenance treatment in AML patients undergoing … Recruiting
  2024-512752-38-00 5 2025-09-09 Adjunctive and maintenance treatment to HCT
• Study to evaluate the efficacy and safety of [177Lu]Lu-DOTA-TATE in patients with Grade 1 and Grade 2 advanced GEP-NET (NETTER-3) Recruiting
  2024-518325-15-00 5 2025-09-08 Gastroenteropancreatic neuroendocrine tumor (GEP-NET)
• Saccharomyces boulardii CNCM I-745 in Irritable Bowel Syndrome. Recruiting
  2024-520276-10-00 5 2025-09-04 Non-constipated Irritable Bowel Syndrome (IBS)
• A study to evaluate acalabrutinib, in combination with the R-CHOP standard of care, for previously untreated mantle cell lymphoma in Spain. Recruiting
  2025-521152-34-00 4 2025-09-04 mantle cell lymphoma (MCL)
• A Study to Compare the Efficacy and Safety of Golcadomide in Combination with Rituximab (Golca + R) vs Investigator’s Choice in Participants … Recruiting
  2024-519152-82-00 5 2025-09-03 Relapsed/Refractory Follicular Lymphoma
• A Trial to Test How AZD0780 Affects Serious Heart, Stroke, or Vascular Problems in Patients with Heart, Stroke or Vascular Disease or at Hig … Recruiting
  2025-520519-14-00 5 2025-09-03 Atherosclerotic Cardiovascular Disease
• A clinical study of MK-5684 in people with certain solid tumors (MK-5684-015) Recruiting
  2024-519563-18-00 10 2025-09-02 Breast cancer, Ovarian cancer, Endometrial cancer
• A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients with Heart Failure Who Are Intolerant or Not Eligible for Treatme … Recruiting
  2023-508875-35-00 5 2025-09-01 Heart condition
• Long-term follow-up of patients previously treated with autologous T cells genetically modified with viral vectors. Recruiting
  2024-511684-28-00 4 2025-09-01 Potential malignancy in patients who received treatment with Autolus C
• A first-in-human study of KK8123 in adults with X-linked hypophosphatemia Recruiting
  2023-509390-23-00 1 2025-08-29 X-linked hypophosphatemia.
• ENGIC 01 - COLOSOTO: A single-arm phase II study evaluating 5-fluorouracil plus Panitumumab (anti-EGFR) and Sotorasib (KRAS G12C inhibitor) … Recruiting
  2024-514030-20-00 4 2025-08-29 colorectal cancer
• A clinical study of combination therapies in people with kidney cancer (MK-3475-03C) Recruiting
  2024-516437-12-00 9 2025-08-29 Clear cell renal cell carcinoma
• A Study to Assess Adverse Events, and How Intravenously (IV) Infused ABBV-969 Moves Through the Bodies of Adult Participants With Metastatic … Recruiting
  2024-516772-15-00 1 2025-08-29 Prostate Cancer
• A Phase 1 Study of Healthy Donor CD19-targeted Allogeneic CAR T Cells in Participants with Severe, Refractory Autoimmune Diseases Recruiting
  2024-517681-41-00 1 2025-08-29 Systemic Sclerosis
• A Phase 2 study of JNJ-90301900 with chemoradiation and durvalumab for non-small cell lung cancer Recruiting
  2024-518276-32-00 4 2025-08-29 Locally advanced and unresectable Stage III non-small cell lung cancer
• A Global, Randomized, Open-label, Multicenter Phase 3 Trial Evaluating BJT-778 vs Bulevirtide for the Treatment of Chronic Hepatitis Delta I … Recruiting
  2024-517167-23-00 5 2025-08-28 Chronic Hepatitis D Infection
• Study of Daraxonrasib (RMC-6236) in Patients with RAS Mutated NSCLC Recruiting
  2024-518154-16-00 5 2025-08-27 non-small cell lung cancer
• A Phase 3, placebo-controlled study to investigate LP352 in children and adults with Developmental and Epileptic Encephalopathies Recruiting
  2024-516412-17-00 5 2025-08-26 Developmental and Epileptic Encephalopathies (DEE)
• A Study to Evaluate the Safety and Effectiveness of ALKS 2680 in Subjects With Idiopathic Hypersomnia Recruiting
  2025-520981-23-00 4 2025-08-26 Idiopathic Hypersomnia (IH)

Showing 961–984 of 3,550 trials